期刊文献+
共找到3,238篇文章
< 1 2 162 >
每页显示 20 50 100
Chemotherapy combined with bevacizumab for small cell lung cancer with brain metastases:A case report
1
作者 Hong-Yu Yang Yu-Qing Xia +3 位作者 Yu-Jia Hou Peng Xue Shi-Jie Zhu Dian-Rong Lu 《World Journal of Clinical Cases》 SCIE 2024年第2期405-411,共7页
BACKGROUND Small cell lung cancer(SCLC)is a common and aggressive subtype of lung cancer.It is characterized by rapid growth and a high mortality rate.Approximately 10%of patients with SCLC present with brain metastas... BACKGROUND Small cell lung cancer(SCLC)is a common and aggressive subtype of lung cancer.It is characterized by rapid growth and a high mortality rate.Approximately 10%of patients with SCLC present with brain metastases at the time of diagnosis,which is associated with a median survival of 5 mo.This study aimed to summarize the effect of bevacizumab on the progression-free survival(PFS)and overall survival of patients with brain metastasis of SCLC.CASE SUMMARY A 62-year-old man was referred to our hospital in February 2023 because of dizziness and numbness of the right lower extremity without headache or fever for more than four weeks.The patient was diagnosed with limited-stage SCLC.He received 8 cycles of chemotherapy combined with maintenance bevacizumab therapy and achieved a PFS of over 7 mo.CONCLUSION The combination of bevacizumab and irinotecan effectively alleviated brain metastasis in SCLC and prolonged PFS. 展开更多
关键词 Small cell lung cancer BEVACIZUMAB Brain metastasis antineoplastic agents Target therapies IMMUNOTHERAPY RADIOTHERAPY Case report
下载PDF
Use of albendazole sulfoxide, albendazole sulfone, and combined solutions as scolicidal agents on hydatid cysts (in vitro study) 被引量:19
2
作者 Gokhan Adas Soykan Arikan +3 位作者 Ozgur Kemik Ali Oner Nilgun Sahip Oguzhan Karatepe 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第1期112-116,共5页
AIM: TO establish which scolicidal agents are superior and more suitable for regular use. METHODS: Echinococcus granu/osus protoscoleces were obtained from 25 patients with liver hydatid cysts. Various concentration... AIM: TO establish which scolicidal agents are superior and more suitable for regular use. METHODS: Echinococcus granu/osus protoscoleces were obtained from 25 patients with liver hydatid cysts. Various concentrations of albendazole sulfone, albendazole sulfoxide, and albendazole sulfone and albendazole sulfoxide mixed together in concentrations of 50 μg/mL, and H202 in a concentration of 4%, NaCI 20%, and 1.5% cetrimide-0.15% chlorhexidine (10% Savlon-Turkey) were used to determine the scolicidal effects. Albendazole (ABZ) derivatives and other scolicidal agents were applied to a minimum of 100 scoleces for 5 and 10 min. The degree of viability was calculated according to the number of living scolices per field from a total of 100 scolices observed under the microscope. RESULTS: After 5 min, ABZ sulfone was 97.3% effective, ABZ sulfoxide was 98.4% effective, and the combined solution was 98.6% effective. When sulfone, sulfoxide and the combined solutions were compared, the combined solution seemed more effective than sulfone. However, there was no difference when the combined solution was compared with sulfoxide. After 10 min, hypertonic salt water, sulfone, sulfoxide, and the combined solution compared to other solutions looked more effective and this was statistically significant on an advanced level. When sulfone, sulfoxide, and the combined solutions were compared with each other, the combined solution appeared more effective than sulfone. When the combined solution was compared with sulfoxide, there was no difference. CONCLUSION: Despite being active, ABZ metabolites did not provide a marked advantage over 20% hypertonic saline. According to these results, we think creating a newly improved and more active preparation is necessary for hydatid cyst treatment. 展开更多
关键词 Hydatid disease AIbendazole In vitrostudy combined solution Scolicidal agents
下载PDF
FIRST STEP VIEW OF THE EFFICACY OF ANTINEOPLASTIC AGENTS
3
作者 鱼达 吴金民 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 1995年第2期121-126,共6页
A human K562 leukaemia call and acute adult leudaemia patient samples have been used to test the efficacy of antineoplastic agents with MTT assay.All 18 drugs were invoved.According to the purpose of experiment these... A human K562 leukaemia call and acute adult leudaemia patient samples have been used to test the efficacy of antineoplastic agents with MTT assay.All 18 drugs were invoved.According to the purpose of experiment these durgs were applied at different opportunities or combinations.The drug efficacy has been observed and summarized as four different conditions:1.the change of the time(△ T )closely related with drug effacacy, during the duration the change of drug concentration(△ C) at certain extent has almost no influence; 2the △ C closely related with the efficacy, the △ T has no influence;3. The △ C and △ T effect the results together;and 4.the △ C and △ T effect not the result. And then draw a conclution that the process or drug effacacy has a multiple function with flat distrtct. 展开更多
关键词 antineoplastic agents PHARMACODYNAMICS Acute leukaemia Drug effective test.
下载PDF
Radiomics in Antineoplastic Agents Development:Application and Challenge in Response Evaluation
4
作者 Jiazheng Li Lei Tang 《Chinese Medical Sciences Journal》 CAS CSCD 2021年第3期187-195,共9页
The recent spring up of the antineoplastic agents and the prolonged survival bring both challenge and chance to radiological practice.Radiological methods including CT,MRI and PET play an increasingly important role i... The recent spring up of the antineoplastic agents and the prolonged survival bring both challenge and chance to radiological practice.Radiological methods including CT,MRI and PET play an increasingly important role in evaluating the efficacy of these antineoplastic drugs.However,different antineoplastic agents potentially induce different radiological signs,making it a challenge for radiological response evaluation,which depends mainly on one-sided morphological response evaluation criteria in solid tumors(RECIST)in the status quo of clinical practice.This brings opportunities for the development of radiomics,which is promising to serve as a surrogate for response evaluations of anti-tumor treatments.In this article,we introduce the basic concepts of radiomics,review the state-of-art radiomics researches with highlights of radiomics application in predictions of molecular biomarkers,treatment response,and prognosis.We also provide in-depth analyses on major obstacles and future direction of this new technique in clinical investigations on new antineoplastic agents. 展开更多
关键词 radiomics deep learning machine learning antineoplastic agents response evaluation
下载PDF
The combined time-frequency analysis of the acoustic signals backscattered from ultrasonic contrast agents in the evaluation of the blood perfusion
5
作者 李彬 万明习 王素品 《Journal of Medical Colleges of PLA(China)》 CAS 2004年第4期222-224,共3页
Objective: To analyze the non-periodic, unstable and even chaotic echoes scattered from microbubbles which are extremely sensitive and may easily collapse, fragment or shrink when ultrasound contrast agents are expose... Objective: To analyze the non-periodic, unstable and even chaotic echoes scattered from microbubbles which are extremely sensitive and may easily collapse, fragment or shrink when ultrasound contrast agents are exposed to ultrasound (US) irradiation. Methods: The combined time-frequency analysis was applied to the original signals instead of the traditional Fourier spectral analysis technique. Results: The results obtained from simulation as well as experiment showed that the subharmonic, 2nd harmonic and ultra harmonic of the microbubbles occurred during the oscillation and varied with time. The dependence on the incident ultrasonic amplitude and microbubble parameters were established. Conclusion: The transient echoes backscattered from the ultrasound agent in the evaluation of the blood perfusion can be analyzed thoroughly by the technique of combined-frequency analysis and the time detail of the frequency contents can be revealed. 展开更多
关键词 ultrasound contrast agent HARMONIC combined time-frequency analysis
下载PDF
Antiangiogenic agents combined with chemotherapy in non-small cell lung cancer
6
作者 Shanshan Chen Shun Lu 《The Chinese-German Journal of Clinical Oncology》 CAS 2015年第2期58-64,共7页
As a targeted therapy, antiangiogenic treatment has been increasingly studied for advanced non-small cell lung cancer(NSCLC) and has proven effective for the treatment of advanced NSCLC. Bevacizumab, a monoclonal anti... As a targeted therapy, antiangiogenic treatment has been increasingly studied for advanced non-small cell lung cancer(NSCLC) and has proven effective for the treatment of advanced NSCLC. Bevacizumab, a monoclonal antibody targeting angiogenesis, is the only antiangiogenic agent approved for use in combination with first-line chemotherapy for non-squamous NSCLC. Small-molecule inhibitors targeting the tyrosine kinase receptor have also shown promise when combined with standard chemotherapeutic agents in patients with advanced NSCLC. However, unlike bevacizumab, not all other antiangiogenic agents show significant benefits when combined with chemotherapy. As for the failures of most other combinations, the combination schedule may be an important reason that has so far been overlooked in clinical trials. This article reviews the combination of angiogenic agents with chemotherapy in the treatment of NSCLC. 展开更多
关键词 non-small cell lung cancer (NSCLC) antiangiogenic agent CHEMOTHERAPY combination schedule
下载PDF
Treatment of malignant digestive tract obstruction by combined intraluminal stent installation and intra-arterial drug infusion 被引量:6
7
作者 Ai-Wu Mao Zhong-Du Gao Jia-Yu Xu Ren-Jie Yang Xiang-Seng Xiao Ting-Hui Jiang Wei-Jun Jiang Department of Interventional Radiology,Shanghai S.T,Luke’s Hospital,768 Yu Yuan Road,Shanghai 200050,ChinaDepartment of Gastroenterology Rui Jin Hospital,Shanghai Second Medical University,Departrnent of Tumor Hospital,Beijing Medical UniversityDepartment of Imaging Chang Zheng Hospital,Shanghai Second Military Medical University 《World Journal of Gastroenterology》 SCIE CAS CSCD 2001年第4期587-592,共6页
AIM: To study the palliative treatment of malignant obstruction of digestive tract with placement of intraluminal stent combined with intra-arterial infusion of chemotherapeutic drugs. METHODS: A total of 281 cases of... AIM: To study the palliative treatment of malignant obstruction of digestive tract with placement of intraluminal stent combined with intra-arterial infusion of chemotherapeutic drugs. METHODS: A total of 281 cases of digestive tract malignant obstruction were given per oral (esophagus, stomach, duodenum and jejunum), per anal (colon and rectum) and percutaneous transhepatic (biliary) installation of metallic stent. Among them, 203 cases received drug infusion by cannulation of tumor supplying artery with Seldinger's technique. RESULTS: Altogether 350 stents were installed in 281 cases, obstructive symptoms were relieved or ameliorated after installation. Occurrence of restenotic obstruction was 8-43 weeks among those with intra-arterial drug infusion, which was later than 4-26 weeks in the group with only stent installation. The average survival time of the former group was 43 (3-105) weeks, which was significantly longer than 13 (3-24) weeks of the latter group. CONCLUSION: Intraluminal placement of stent combined with intra-arterial infusion chemotherapy is one of the effective palliative therapies for malignant obstruction of the digestive tract with symptomatic as well as etiological treatment. 展开更多
关键词 STENTS Adult Aged Aged 80 and over antineoplastic agents DOSAGE combined Modality Therapy Female Gastrointestinal Neoplasms Humans Infusions Intra-Arterial Intestinal Obstruction Male Middle Aged Palliative Care Quality of Life Treatment Outcome
下载PDF
Combined therapeutic effects of cytotoxic agent and differentiation-inducer on human gastric carcinoma cell line SGC-7901
8
作者 夏锋 王代科 +3 位作者 刘宝华 冯素珍 陈琳 李义兵 《Journal of Medical Colleges of PLA(China)》 CAS 2000年第2期128-130,共3页
Objective:To study the combined therapeutic effects of cytotoxic agent and differentiation-inducer on human gas tric carcinoma celll line SGC-7901 in vitro. Methods: The combined therapeutic effects of all-trans retin... Objective:To study the combined therapeutic effects of cytotoxic agent and differentiation-inducer on human gas tric carcinoma celll line SGC-7901 in vitro. Methods: The combined therapeutic effects of all-trans retinoic acid (ATRA), interferon a (IFNa)and fluorouracil (5-Fu) on gastric carcinoma cell line ax 7901 were observed when one of the 3, the combination of any 2 of the 3 and combination of all the 3 were administered respectively. The morphological and functional changes of gastric carcinoma cells were studied with MTT assay, flow cytometry, image analysis and determination of CEA content in the culture medium of the cells. Results: The cytostatic rate was increased as shown by the decrease of the rate of colony formation of the cells on culture disc when one agent, the combination of 2 agents and the combination of the 3 were administered progressively. The cells were relatively accumulated in the phase of G0/G1 and synthesis of DNA in he cells was inhibited.The malignant phenotype of the cells disappeared gradually while the characteristics of matUre cells were in creased. Meanwhile, CEA Level in the culture medium was decreased progressively. Apoptosis of the cells was oborved and a large amount of apoptotic apoptotic were found. Conclusion: The administration of the 3 agents in combination result in signif icant inhibition on proliferation, inducing of differention and promotion of apoptosis of gastric caxcinoma cells. The combina tion of cytotoxic agent and differention-inducer exerts significant inhibition on gastric carcinoma cells in vitro. 展开更多
关键词 all-transretinoic acid interferon a combined therapy of CYTOTOXIC agent and differentiation- INDUCER gastric carcinoma
下载PDF
Time-limited,Combined Regimen in Chronic Lymphocytic Leukemia:A Promising Strategy to Achieve a Drug Holiday 被引量:2
9
作者 Rui JIANG Jian-yong LI Hua-yuan ZHU 《Current Medical Science》 SCIE CAS 2021年第3期431-442,共12页
Chemoimmunotherapy(CIT)is defined as standard first line treatment for chronic lymphocytic leukemia(CLL)patients while patients with unfavorable biological characteristics such as unmutated immunoglobulin heavy chain(... Chemoimmunotherapy(CIT)is defined as standard first line treatment for chronic lymphocytic leukemia(CLL)patients while patients with unfavorable biological characteristics such as unmutated immunoglobulin heavy chain(UM-IGHV)and TP53 aberration failed to benefit from it.The emergency of the small molecular targeted agents including Bruton’s tyrosine kinase(BTK)inhibitor(BTKi)leads to a brand-new era,from a CIT to a chemo-free era in CLL.However,the treatment of target agents is not enough to attain a deep remission and high rate of complete remission(CR),especially in patients with high risks.The long duration brought about problems,such as cost,drug resistance and toxicity.To benefit CLL in progression free survival(PFS)and long-term remission,exploration of time-limited therapies,mainly with BTKi plus CIT and BCL2i based combination therapy has become a mainstream in clinical trials.The time-limited combination therapy shed light on the promising potentiality to attain sustainable deep remission and partly overcame the risk factors,although long term follow-up is required to consolidate the conclusion.In this review,we intend to introduce key results of clinical trials with combination therapy,discuss the achievements and limitations and put forward future direction for clinical trial design in this field. 展开更多
关键词 small molecular targeted agents Bruton's tyrosine kinase inhibitor chronic lymphocytic leukemia CHEMOIMMUNOTHERAPY COMBINATION
下载PDF
Combined Ang-2 and VEGF Targeting Therapies in Renal Cell Carcinoma 被引量:1
10
作者 Nikolett Molnar Dietmar W. Siemann 《Journal of Cancer Therapy》 2013年第9期1-6,共6页
Angiogenesis, the growth of new vessels from pre-existing ones, is an important feature of tumor growth that has been exploited as a therapeutic target in oncology. Given its key role in facilitating blood vessel spro... Angiogenesis, the growth of new vessels from pre-existing ones, is an important feature of tumor growth that has been exploited as a therapeutic target in oncology. Given its key role in facilitating blood vessel sprouting, VEGF has been a major focus of anti-angiogenic strategies, but the observation of resistance in some clinical trials utilizing such agents has led to a search for new or complementary targets in angiogenesis process. The Angiopoietin/Tie2 pathway and in particular the Angiopoietin-2 (Ang-2) ligand which is critically involved in the destabilization of normal vasculature, has been identified as one such target. The current study investigated the potential benefits of combining an Ang-2 targeted therapy with small molecule VEGF targeted agents (Sunitinib, Cediranib) in a human renal cell carcinoma model. The results showed that while both Ang-2 and VEGF interference on their own impaired tumor growth and new blood vessel formation, the combination of agents that targeted both pathways resulted in significantly superior anti-tumor and anti-angiogenic effects. 展开更多
关键词 ANGIOPOIETIN-2 ANGIOGENESIS ANTI-ANGIOGENIC Agent Combination Therapy Vascular ENDOTHELIAL Growth Factor
下载PDF
煤矿井下掘进机器人路径规划方法研究 被引量:2
11
作者 张旭辉 郑西利 +4 位作者 杨文娟 李语阳 麻兵 董征 陈鑫 《煤田地质与勘探》 EI CAS CSCD 北大核心 2024年第4期152-163,共12页
针对煤矿非全断面巷道条件下掘进机器人移机难度大、效率低下等问题,分析了煤矿井下非结构化环境特征及掘进机器人运动特性,提出了基于深度强化学习的掘进机器人机身路径规划方法。利用深度相机将巷道环境实时重建,在虚拟环境中建立掘... 针对煤矿非全断面巷道条件下掘进机器人移机难度大、效率低下等问题,分析了煤矿井下非结构化环境特征及掘进机器人运动特性,提出了基于深度强化学习的掘进机器人机身路径规划方法。利用深度相机将巷道环境实时重建,在虚拟环境中建立掘进机器人与巷道环境的碰撞检测模型,并使用层次包围盒法进行虚拟环境碰撞检测,形成巷道边界受限下的避障策略。考虑到掘进机器人形体大小且路径规划过程目标单一,在传统SAC算法的基础上引入后见经验回放技术,提出HER-SAC算法,该算法通过环境初始目标得到的轨迹扩展目标子集,以增加训练样本、提高训练速度。在此基础上,基于奖惩机制建立智能体,根据掘进机器人运动特性定义其状态空间与动作空间,在同一场景下分别使用3种算法对智能体进行训练,综合平均奖励值、最高奖励值、达到最高奖励值的步数以及鲁棒性4项性能指标进行对比分析。为进一步验证所提方法的可靠性,采用虚实结合的方式,通过调整目标位置设置2种实验场景进行掘进机器人的路径规划,并将传统SAC算法和HER-SAC算法的路径结果进行对比。结果表明:相较于PPO算法和SAC算法,HER-SAC算法收敛速度更快、综合性能达到最优;在2种实验场景下,HER-SAC算法相比传统SAC算法规划出的路径更加平滑、路径长度更短、路径终点与目标位置的误差在3.53 cm以内,能够有效地完成移机路径规划任务。该方法为煤矿掘进机器人的自主移机控制奠定了理论基础,为煤矿掘进设备自动化提供了新方法。 展开更多
关键词 掘进机器人 路径规划 深度强化学习 智能体 虚实结合 改进SAC算法 煤矿
下载PDF
四联方案预防含顺铂方案多日化疗致恶心呕吐的效果和安全性研究
12
作者 秦汉林 胡长路 +1 位作者 赵亚梅 牛维纳 《天津医药》 CAS 2024年第8期835-839,共5页
目的评价四联方案预防含顺铂方案多日化疗所致恶心呕吐(CINV)的有效性和安全性。方法选取以含顺铂药物进行化疗的112例恶性肿瘤患者。以随机数字表法将患者分为试验组与对照组,每组56例。对照组接受含有顺铂的化疗方案时给予三联方案(... 目的评价四联方案预防含顺铂方案多日化疗所致恶心呕吐(CINV)的有效性和安全性。方法选取以含顺铂药物进行化疗的112例恶性肿瘤患者。以随机数字表法将患者分为试验组与对照组,每组56例。对照组接受含有顺铂的化疗方案时给予三联方案(福沙匹坦双葡甲胺+盐酸昂丹司琼+地塞米松),试验组在对照组基础上给予含奥氮平的四联方案。观察2组恶心及呕吐发生情况、生活质量[呕吐生活功能量表(FILE)]及焦虑抑郁[医院焦虑抑郁量表(HADS)]的变化。结果开始化疗后1~9 d,试验组恶心、呕吐发生率低于对照组,试验组延迟期恶心、呕吐发生率低于对照组(P<0.05);开始化疗后9 d,试验组FILE的恶心、呕吐及总分高于对照组(P<0.05);2组开始化疗后1、9 d焦虑、抑郁评分及不良反应发生率比较差异无统计学意义(P>0.05)。结论四联止吐方案可提高对含顺铂多日化疗方案致CINV的控制率,尤其是针对延迟性恶心、呕吐的控制,改善患者化疗期间的生活质量,且安全性较好。 展开更多
关键词 顺铂 抗肿瘤联合化疗方案 恶心 呕吐 药物评价
下载PDF
安罗替尼致高血压文献病例分析
13
作者 王春晖 宋承誉 吴薇 《实用药物与临床》 CAS 2024年第4期285-290,共6页
目的探讨安罗替尼相关高血压的临床特点。方法检索中国知网、万方、PubMed、Web of Science数据库(截至2023年7月31日),收集安罗替尼相关高血压文献病例报告类文献,提取患者基本情况、安罗替尼用药情况、高血压情况、干预措施和转归等,... 目的探讨安罗替尼相关高血压的临床特点。方法检索中国知网、万方、PubMed、Web of Science数据库(截至2023年7月31日),收集安罗替尼相关高血压文献病例报告类文献,提取患者基本情况、安罗替尼用药情况、高血压情况、干预措施和转归等,进行描述性统计分析。结果纳入分析的文献为16篇,患者18例,男性8例,女性10例;年龄27~76岁,平均58岁;非小细胞肺癌13例,结缔组织和软组织恶性肿瘤2例,肝内胆管癌1例,卵巢癌1例,子宫癌1例。联用其他抗肿瘤药物4例;安罗替尼初始剂量均为12 mg/d。发生的高血压分级为1级3例(17%),2级4例(22%),3级9例(50%),4级2例(11%)。除8例患者从服用安罗替尼至发生高血压的时间不详外,其余10例患者从服用安罗替尼至发生高血压的时间在7 d~6个月内,中位时间36(30,42)d,其中7例(39%)发生在服用安罗替尼2个月内。18例患者中出现不同程度乏力6例(33%),头痛6例(33%),头晕5例(28%),呕吐3例(17%),视物模糊2例(11%),恶心1例(6%),抽搐1例(6%)。13例伴其他不良反应,其中手足综合征7例(39%),蛋白尿3例(17%),高脂血症3例(17%),可逆性后部白质脑病综合征2例(11%),癫痫1例(6%),便血1例(6%),皮疹1例(6%)。1~2级患者安罗替尼未调整(6例)或减量治疗(1例)后耐受良好;3~4级患者中,8例停用安罗替尼且接受降压药治疗,2例减量治疗,1例未调整,随访血压控制平稳。结论安罗替尼相关高血压多发生在用药2个月内,往往伴其他不良反应,3级以上高血压常见,但大多数患者经对症处理、停药或减量后转归良好。 展开更多
关键词 抗肿瘤药 安罗替尼 血管生成抑制剂 高血压 不良反应
下载PDF
弥漫内生型脑桥胶质瘤放化疗及靶向治疗单中心研究
14
作者 张静 王鹏 邱晓光 《中国现代神经疾病杂志》 CAS 北大核心 2024年第9期732-738,共7页
目的探索弥漫内生型脑桥胶质瘤(DIPG)的有效治疗方法及生存影响因素。方法回顾分析2021年4月至2024年1月首都医科大学附属北京天坛医院采用放射治疗联合替莫唑胺和尼妥珠单抗化疗或放射治疗联合ACT001化疗的14例儿童DIPG患者的临床和影... 目的探索弥漫内生型脑桥胶质瘤(DIPG)的有效治疗方法及生存影响因素。方法回顾分析2021年4月至2024年1月首都医科大学附属北京天坛医院采用放射治疗联合替莫唑胺和尼妥珠单抗化疗或放射治疗联合ACT001化疗的14例儿童DIPG患者的临床和影像学信息及生存资料,采用Kaplan⁃Meier生存曲线计算中位无进展生存期和总生存期,多变量Cox比例风险回归分析各项因素对无进展生存期和总生存期的影响。结果共14例患儿的客观缓解率为10/14,中位无进展生存期7.83个月,中位总生存期8.30个月。基线影像学无强化是无进展生存期延长的保护因素(RR=0.052,95%CI:0.006~0.416;P=0.005);男性(RR=0.085,95%CI:0.009~0.764;P=0.028)、年龄较大(RR=0.631,95%CI:0.423~0.942;P=0.024)、无脑神经受累表现(RR=0.116,95%CI:0.017~0.781;P=0.027)和基线影像学无强化(RR=0.046,95%CI:0.005~0.413;P=0.006)是总生存期延长的保护因素。结论女性、诊断时年龄较小、发病时脑神经受累、基线影像学强化是影响DIPG患儿生存的危险因素。 展开更多
关键词 弥漫性内生型桥脑胶质瘤 放射疗法 抗肿瘤联合化疗方案 分子靶向治疗 儿童
下载PDF
血清miR-345、miR-138及miR-22与晚期胃癌患者化疗敏感性的相关性分析
15
作者 周士霞 王海莉 《医学临床研究》 CAS 2024年第5期711-714,共4页
【目的】探讨血清微小RNA-345(miR-345)、miR-138及miR-22与晚期胃癌患者化疗敏感性的相关性。【方法】100例均接受同一化疗方案治疗的晚期胃癌患者,依据疗效分为有效组(n=69)及无效组(n=31),比较两组临床病理特征及血清相关指标,绘制... 【目的】探讨血清微小RNA-345(miR-345)、miR-138及miR-22与晚期胃癌患者化疗敏感性的相关性。【方法】100例均接受同一化疗方案治疗的晚期胃癌患者,依据疗效分为有效组(n=69)及无效组(n=31),比较两组临床病理特征及血清相关指标,绘制受试者工作特征(ROC)曲线分析血清miR-345、miR-138及miR-22预测晚期胃癌化疗效果的价值,采用多因素Logistic回归分析影响患者化疗效果的因素。【结果】Ⅲ期患者的血清miR-345相对表达量低于Ⅳ期患者,miR-138及miR-22相对表达量高于Ⅳ期患者(P<0.05);有效组miR-345低于无效组,miR-138、miR-22高于无效组(P<0.05)。经ROC曲线分析证实,血清miR-345、miR-138及miR-22能用于预测晚期胃癌的化疗效果,其敏感度与特异性分别为0.855、0.935、0.971、0.839和0.884、0.903(均P<0.05)。多因素Logistic回归分析显示,病理分期为Ⅳ期、miR-345≥14.5、miR-138≤2及miR-22≤3.12为晚期胃癌患者化疗效果不佳的危险因素(P<0.05)。【结论】血清miR-345≥14.5、miR-138≤2、miR-22≤3.12均为导致化疗效果不佳的危险因素,其可作为评估患者化疗效果的生物学标志物。 展开更多
关键词 胃肿瘤 微RNAS 抗肿瘤药 数据相关性
原文传递
Calcium carbonate promotes the formation and stability of soil macroaggregates in mining areas of China
16
作者 Junyu Xie Jianyong Gao +7 位作者 Hanbing Cao Jiahui Li Xiang Wang Jie Zhang Huisheng Meng Jianping Hong Tingliang Li Minggang Xu 《Journal of Integrative Agriculture》 SCIE CAS CSCD 2024年第3期1034-1047,共14页
We studied changes in the concentrations of aggregate-cementing agents after different reclamation times and with different fertilization regimes,as well as the formation mechanism of aggregates in reclaimed soil,to p... We studied changes in the concentrations of aggregate-cementing agents after different reclamation times and with different fertilization regimes,as well as the formation mechanism of aggregates in reclaimed soil,to provide a theoretical basis for rapid reclamation of soil fertility in the subsidence area of coal mines in Shanxi Province,China.In this study,soil samples of 0–20 cm depth were collected from four fertilization treatments of a longterm experiment started in 2008:no fertilizer (CK),inorganic fertilizer (NPK),chicken manure compost (M),and50%inorganic fertilizer plus 50%chicken manure compost (MNPK).The concentrations of cementing agents and changes in soil aggregate size distribution and stability were analysed.The results showed that the formation of>2 mm aggregates,the aggregate mean weight diameter (MWD),and the proportion of>0.25 mm water-stable aggregates (WR_(0.25)) increased significantly after 6 and 11 years of reclamation.The concentration of organic cementing agents tended to increase with reclamation time,whereas free iron oxide (Fed) and free aluminium oxide(Ald) concentrations initially increased but then decreased.In general,the MNPK treatment signi?cantly increased the concentrations of organic cementing agents and CaCO_(3),and CaCO_(3) increased by 60.4%at 11 years after reclamation.Additionally,CaCO_(3) had the greatest effect on the stability of aggregates,promoting the formation of>0.25 mm aggregates and accounting for 54.4%of the variance in the proportion and stability of the aggregates.It was concluded that long-term reclamation is bene?cial for improving soil structure.The MNPK treatment was the most effective measure for increasing maize grain yield and concentration of organic cementing agents and CaCO_(3). 展开更多
关键词 reclamation time manure combined with inorganic fertilizer soil aggregate stability cementing agents CaCO_(3)
下载PDF
Evaluation of the Efficiency of the Magicramp® Device for Reducing Cramps Resulting from Oncological Treatments: “Double-Blind, Randomized Clinical Trial”
17
作者 Sodré Gonçalves de Brito Neto Hector Lutero Honorato de Brito Siman Geraldo Silva Queiroz 《Open Journal of Preventive Medicine》 2024年第5期110-130,共21页
We identified that oncological treatments in general (chemotherapies, immunotherapies and radiotherapies) frequently cause peripheral neuropathy, including cramps, characterized by excess protons due to metabolic and ... We identified that oncological treatments in general (chemotherapies, immunotherapies and radiotherapies) frequently cause peripheral neuropathy, including cramps, characterized by excess protons due to metabolic and neuronal factors, such as sudden changes in pH, uremia and aspects that affect neuromotor functions. Such situations and others like them are often neglected in treatment, which naturally concerns itself with the main problem: Cancer. Sometimes toxic solutions are implemented that have comorbid side effects, such as duloxetine (standard treatment). Based on monitoring of cancer patients who used the non-toxic product, called “Magicramp® Electrostatic Charge Reduction Cushion” (MECRC), approved in Europe more than 10 years ago, we carried out a controlled test in Brazil. In this clinical trial, we hypothesized that reducing excessive ionic charges (electrostatic charge), which is one of the side effects often described in the literature as “Chemotherapy-Induced Peripheral Neuropathy” (CIPN), would decrease or eliminate cramping, under the hypothesis that such elimination would prevent or attenuate muscular vulnerability to action impulses, and increase the power of relaxation through the same mechanism. In this double-blind and randomized clinical trial, 40 (forty) adult patients with muscle cramps caused by oncological treatments were tested, evaluating the degree of efficiency of the product that aims to reduce muscle cramps, by eliminating and/or reducing excess loads electrostatic ionic. Data from the clinical research conducted in this study are available online at https://doi.org/10.7910/DVN/QUS94U. 展开更多
关键词 Muscle Cramp Action Potentials antineoplastic combined Chemotherapy Protocols
下载PDF
西达苯胺联合R-DHAP方案治疗复发/难治性弥漫大B细胞淋巴瘤的临床疗效
18
作者 王晓伟 李宁 +1 位作者 刘婷 王亚琦 《医学临床研究》 CAS 2024年第4期537-539,543,共4页
【目的】探讨西达苯胺联合R-DHAP方案治疗复发/难治性弥漫大B细胞淋巴瘤(DLBCL)的临床疗效。【方法】78例复发/难治性DLBCL患者,随机分为观察组和对照组。对照组采用R-DHAP方案治疗,观察组采用西达苯胺联合R-DHAP方案治疗。比较两组肿... 【目的】探讨西达苯胺联合R-DHAP方案治疗复发/难治性弥漫大B细胞淋巴瘤(DLBCL)的临床疗效。【方法】78例复发/难治性DLBCL患者,随机分为观察组和对照组。对照组采用R-DHAP方案治疗,观察组采用西达苯胺联合R-DHAP方案治疗。比较两组肿瘤患者体力状况(ECOG)评分,临床疗效,血清血管内皮生长因子(VEGF)、β2-微球蛋白(β2-MG)水平,药物不良反应以及无进展生存时间。【结果】治疗3个疗程后,两组ECOG评分较治疗前均降低(P<0.05),且观察组低于对照组(P<0.05);观察组的客观缓解率高于对照组(P<0.05);两组血清VEGF、β2-MG水平均较治疗前降低(P<0.05),且观察组低于对照组(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。观察组和对照组患者中位无进展生存时间分别为20.60个月和15.18个月,两组比较,差异有统计学意义(P<0.05)。【结论】西达苯胺联合R-DHAP方案治疗复发/难治性DLBCL患者能够改善临床症状,疗效确切,同时可以降低血清VEGF、β2-MG水平,延长患者生存时间,且安全可靠。 展开更多
关键词 淋巴瘤 大B细胞 弥漫性/药物疗法 抗肿瘤联合化疗方案 治疗结果
原文传递
儿童胶质瘤诊断与治疗要点及进展
19
作者 杨学军 《中国现代神经疾病杂志》 CAS 北大核心 2024年第9期695-700,共6页
儿童胶质瘤异质性突出,具有独特的分子病理学特征,并非成人胶质瘤的“缩小版”。本文强调儿童胶质瘤手术治疗、放射治疗和药物化疗的基本要点,介绍其与成人胶质瘤靶向治疗的异同,阐述儿童胶质瘤涉及的重要驱动基因异常及其对应的靶向治... 儿童胶质瘤异质性突出,具有独特的分子病理学特征,并非成人胶质瘤的“缩小版”。本文强调儿童胶质瘤手术治疗、放射治疗和药物化疗的基本要点,介绍其与成人胶质瘤靶向治疗的异同,阐述儿童胶质瘤涉及的重要驱动基因异常及其对应的靶向治疗策略,重点描述组蛋白H3突变致儿童弥漫性高级别胶质瘤的表观遗传学治疗策略,并展望儿童胶质瘤诊断与治疗的未来工作。 展开更多
关键词 神经胶质瘤 神经外科手术 放射疗法 抗肿瘤联合化疗方案 分子靶向治疗 表观基因组学 儿童 综述
下载PDF
维奈克拉联合阿扎胞苷与“7+3”方案在新诊断老年急性髓系白血病中近期疗效的初步观察 被引量:2
20
作者 刘霞霞 文晓玲 +7 位作者 黎若祺 张夏林 张恬波 董春霞 王梅芳 张建华 杨林花 张睿娟 《中国实验血液学杂志》 CSCD 北大核心 2024年第1期96-103,共8页
目的:比较维奈克拉(VEN)联合阿扎胞苷(AZA)与标准“7+3”方案诱导治疗新诊断老年急性髓系白血病(AML)的近期疗效及不良反应。方法:回顾性分析山西医科大学第二医院和山西白求恩医院自2021年1月至2022年1月间接受VEN+AZA方案(41例)或“7+... 目的:比较维奈克拉(VEN)联合阿扎胞苷(AZA)与标准“7+3”方案诱导治疗新诊断老年急性髓系白血病(AML)的近期疗效及不良反应。方法:回顾性分析山西医科大学第二医院和山西白求恩医院自2021年1月至2022年1月间接受VEN+AZA方案(41例)或“7+3”方案(38例)诱导治疗且资料完整的79例老年AML患者的临床数据,采用倾向性评分匹配法(PSM)均衡组间混杂因素后,比较组间缓解率、总生存时间(OS)、无进展生存时间(PFS)以及不良反应。结果:VEN+AZA组总反应率(ORR)为68%,“7+3”组为84%,其中复合缓解率(CR+CRi;CRc)分别为64%和72%,两组ORR(P=0.185)及CRc(P=0.544)均无统计学差异。VEN+AZA组的5例未缓解(NR)患者中,4例伴7号染色体异常(7q-/-7),1例伴ETV6基因突变。两组中位随访时间分别为8和12个月,6个月OS、PFS率均无统计学差异(84%vs 92%,P=0.389;84%vs 92%,P=0.258)。两组的血液学不良反应主要是Ⅲ-Ⅳ级骨髓抑制,其发生率比较无统计学意义(P>0.05)。两组中性粒细胞恢复中位时间分别为27(11-70)和25(14-61)d(P=0.161),血小板恢复中位时间分别为27(11-75)和25(16-50)d(P=0.270),差异无统计学意义。VEN+AZA组感染发生率低于“7+3”方案组(56%vs 88%,P=0.012),两组肺部感染率分别为36%和64%(P=0.048),差异均有统计学意义。结论:VEN+AZA和标准“7+3”方案治疗新诊断老年AML的近期疗效相近,但VEN+AZA组感染发生率低。伴有7号染色体异常(7q-/-7)可能是老年AML患者接受VEN+AZA治疗的不良预后因素。 展开更多
关键词 急性髓系白血病 维奈克拉 抗肿瘤联合化疗方案 疗效 安全性
原文传递
上一页 1 2 162 下一页 到第
使用帮助 返回顶部